糖尿病
医学
人体生理学
流行病学
中国
重症监护医学
内科学
历史
内分泌学
考古
出处
期刊:Diabetologia
[Springer Nature]
日期:2018-02-01
卷期号:61 (6): 1249-1260
被引量:384
标识
DOI:10.1007/s00125-018-4557-7
摘要
The People’s Republic of China (herein referred to as China) has witnessed one of the most dramatic rises in diabetes prevalence anywhere in the world. The latest epidemiological study suggests that approximately 11% of the population has diabetes, with a significant proportion remaining undiagnosed. Risk factors for diabetes in the Chinese population are similar to those in other populations, though gestational diabetes and young-onset diabetes is becoming increasingly common. Data on the prevalence of diabetic complications remain limited, though cardio–renal complications account for significant morbidity and mortality. Other diabetes-related comorbidities are becoming increasingly common, with cancer emerging as a major cause of mortality among individuals with diabetes. There are many challenges and obstacles that impede effective diabetes prevention and the delivery of care, though much progress has occurred over recent years. Lessons learnt from how China has responded to the challenges posed by the diabetes epidemic will be invaluable for other countries facing the many threats of diabetes and its complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI